Is measuring serum antioxidant capacity clinically useful?

Annals of Clinical Biochemistry

Volumn 35, Issue 1, 1998, Pages 48-56

  Woodford, F P ^a   Whitehead, T P ^b  

^a Department of Health ^*  (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Diabetes, cancer and atherosclerosis; Research opportunities; Scavenging and chelating antioxidants; Wine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LIPID; LIPID PEROXIDE; LIPOPROTEIN; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TOCOPHEROL; VITAMIN;

ABSORPTIOMETRY; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; ATHEROGENESIS; BLOOD LEVEL; CHEMOLUMINESCENCE; DIABETES MELLITUS; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; MALE INFERTILITY; METHODOLOGY; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; REPERFUSION INJURY; RHEUMATOID ARTHRITIS; SEPTIC SHOCK;

EID: 0031983704     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500105     Document Type: Article

References (60)

1. Grootveld M, Halliwell B. Measurement of allantion and uric acid in human body fluids: a potential index of free-radical reactions in vivo? Biochem J 1987; 243: 803-8
2. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28
3. Gey KF. Cardiovascular disease and vitamins. Concurrent correction of 'suboptimal' plasma antioxidant levels may help to prevent early stages of cardiovascular disease and cancer. Bibl Nutr Dieta 1995; 52: 75-91
4. Schorah CJ. Micronutrients, antioxidants and risk of cancer [Review]. Bibl Nutr Dieta 1995; 52: 92-107
5. Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KLM, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 1996; 17: 559-62
6. Schwartz JL. The dual roles of nutrients as antioxidants and prooxidants: their effects on tumour cell growth [Review]. J Nutr 1996; 126 (suppl 4): 1221S-1227S
7. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin F. and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35
8. Steinberg D. The oxidative modification hypothesis of atherogenesis: strengths and weaknesses. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis X. Amsterdam: Elsevier, 1995: 25-9
9. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-9
10. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci F, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993; 328: 1450-6
11. Salonen JT, Salonen R, Penttila I, Herranen J, Janhiainen M, Kantola M, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985; 56: 226-31
12. Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Lear A, Hermus RJ, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987; 45: 462-8
13. Hense HW, Stender M, Bors W, Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103: 21-8
14. Kristenson H, Ziedén B, Kucinskienë Z, Elinder LS, Bergdahl B, Elwing B, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ 1997; 314: 629-33
15. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Hitchinson MJ, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996; 347: 781-6
16. 1 and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci USA 1997; 94: 3217-22
17. Buettner GR. The pecking order of free radical and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 1993; 300: 535-43
18. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748-52
19. Nyyssönen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314: 634-8
20. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279-93
21. Wayner DDM, Burton GW, Ingold KU, Locke S. Quantitative measurement of the total peroxyl radical-trapping antioxidant capacity of human blood plasma by controlled peroxidation. FEBS Lett 1985; 187: 33-7
22. Nakamura K, Endo H, Kashiwasaki S. Serum oxidation activities and rheumatoid arthritis. Int J Tissue Res 1987; 9: 307-16
23. DeLange RJ, Glazer AN. Phycoerythrin fluorescence-based assay for peroxy radicals: a screen for biologically relevant protective agents. Analyt Biochem 1989; 177: 300-6
24. Arshod MAQ, Bhadra S, Cohen RM, Subbioh MTR. Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin Chem 1991; 37: 1756-8
25. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84: 407-12
26. Maxwell SR, Thorpe GHG, Whitehead TP. An enhanced chemiluminescent assay for antioxidant capacity in biological fluids. In: Galteau MM, Siest G, Henny J, eds. Biologie Prospective. Paris: John Libbey Eurotext, 1993: 519-22 [Fuller version of Whitehead TP, Thorpe GHG, Maxwell SRJ. Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992; 266: 265-77]
27. Maxwell SR, Thorpe GHG, Whitehead TP. An enhanced chemiluminescent assay for antioxidant capacity in biological fluids. In: Galteau MM, Siest G, Henny J, eds. Biologie Prospective. Paris: John Libbey Eurotext, 1993: 519-22 [Fuller version of Whitehead TP, Thorpe GHG, Maxwell SRJ. Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992; 266: 265-77]
28. Schofield D, Braganza JM. Shortcomings of an automated assay for total antioxidant status in biological fluids. Clin Chem 1996; 42: 1712-4
29. Tietz NW, ed. Textbook of Clinical Chemistry. Philadelphia: Saunders, 1986
30. Miller NJ, Rice-Evans CA. Spectrophotometric determination of antioxidant activity. Redox Report 1996; 2: 161-71
31. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides antioxidant defense in humans against oxidant and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-62
32. Smart D, McCusker CA, Lamont JV, Fitzgerald SP, Temmi C, Lapin A. Total antioxidant status and glutathione reductase in geriatric subjects [Abstract]. Proceedings of the ACB National Meeting. London: ACB, 1997: 45-6
33. Miller NJ, Rice-Evans CA. Antioxidant activity of resveratrol in red wine [Letter]. Clin Chem 1995; 41: 1789
34. Vang O, Rasmussen BF, Sorensen H, Clausen J, Andersen O. Effects of dietary broccoli on antioxidant enzymes. Clin Chem 1995; 41: 1910-1
35. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary artery disease in men. Lancet 1991; 338: 464-8
36. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-7
37. Goldberg DM. Does wine work? Clin Chem 1995; 41: 156
38. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995; 41: 32-5
39. Day A, Stansbie D. Cardioprotective effect of red wine may be mediated by urate. Clin Chem 1995; 41: 1319-20
40. Wickramasinghe SN, Hasan R, Khalpey Z. Differences in the serum levels of acetaldehyde and cytotoxic acetaldehyde-albumin complexes after the consumption of red and white wine: in vitro effects of flavonoids, vitamin E, and other dietary antioxidants on cytotoxic complexes. Alcohol Clin Exp Res 1996; 20: 799-803
41. Maxwell SRJ, Jakeman P, Thomason H. Leguen C, Thorpe GHG. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic Res 1993; 19: 191-202
42. Jakeman P, Maxwell S. Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise. Eur J Appl Physiol 1993; 67: 426-30
43. Komosinska K, Olcyk K. The role of free radicals in the pathogenesis of insulin-dependent diabetes mellitus. Postepy High I Med Dosw 1995; 49: 733-46
44. Somogyi A, Pusztai P, Prechl J, Feher J. A dibetes mellitus es szabad gyokos reakciok feltetelezett kapscolata az erelmeszes edessel [Hypothetical connection between diabetes mellitus and free radical reactions in arteriosclerosis]. Orv Hetil 1994; 135: 1815-8
45. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010-4
46. Fuller CJ, Chandalia M, Garg A, Grundy SM, Jiahal I. RRR-alpha-tocopheryl acetate supplementation at pharmacological doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes. Am J Clin Nutr 1995; 63: 753-9
47. MacRury SM, Gordon D, Wilson R, Bradley H, Gemmell CG, Paterson JR, et al. A comparison of different methods of assessing free radical activity in type 2 diabetes and peripheral vascular disease. Diabet Med 1993; 10: 331-5
48. Nhadimana J, Dorchy H, Vertongen F. Activité anti-oxydante erythrocytaire et plasmatique dans le diabète de type I. Presse Mèd 1996; 25: 188-92
49. Gerster H. Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis [review]. Z Ernährungswiss 1993; 32: 243-61
50. Armstrong AM, Chestnutt JE, Gormley MJ, Young IS. The effect of dietary treatment on lipid peroxidation and antioxidant status in newly diagnosed noninsulin-dependent diabetes. Free Radic Biol Med 1996; 21: 719-26
51. Maxwell SRJ, Wiklund O, Bonders G. Measurement of antioxidant activity in lipoproteins using enhanced chemiluminescence. Atherosclerosis 1994; 111: 79-89
52. Blann AD, Maxwell SRJ, Burrows G, Miller JP. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease. Atherosclerosis 1995; 116: 191-8
53. Stansbie D, Day AP, Hayes N. Serum total antioxidant capacity and predisposition to coronary heart disease in healthy young men [Abstract]. Proceedings of the ACB National Meeting. London: ACB, 1997: 29-30
54. Galley HF, Richardson N, Howdle PD, Walker BE, Webster NR. Total antioxidant capacity and lipid peroxidation during liver transplantation. Clin Sci 1995; 89: 329-32
55. Khaira HS, Maxwell SRJ, Thomason H, Thorpe GHG, Green MA, Shearman CP. Antioxidant depletion during aortic aneurysm repair. Br J Surg 1996; 83: 401-3
56. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-8
57. Lewis SEM, Young IS, Boyle PM, Thompson W, McKinney KA. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril 1995; 64: 868-70
58. Smith R, Vantman D, Ponce J, Escobar J, Lissi E. Total antioxidant capacity of human seminal plasma. Hum Reprod 1996; 11: 1655-60
59. Halliwell B, Gutteridge JMC, Blake D. Metal ions and oxygen radical reactions in human inflammatory joint disease. Phil Trans R Soc Lond B 1985; 311: 659-71
60. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994; 53: 51-3